NewAmsterdam Pharma Company N.V. Ordinary Shares (NAMS) is a publicly traded Healthcare sector company. As of August 19, 2026, NAMS trades at $27.10 with a market cap of $3.22B and a P/E ratio of -12.48. NAMS moved +1.30% today. Year to date, NAMS is -22.32%; over the trailing twelve months it is +7.28%. Its 52-week range spans $14.06 to $42.21. Analyst consensus is strong buy with an average price target of $53.29. Rallies surfaces NAMS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
9 analysts cover NAMS: 0 strong buy, 9 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $53.29.
| Metric | Value |
|---|---|
| Price | $27.10 |
| Market Cap | $3.22B |
| P/E Ratio | -12.48 |
| EPS | $-2.16 |
| Dividend Yield | 0.00% |
| 52-Week High | $42.21 |
| 52-Week Low | $14.06 |
| Volume | 828.39K |
| Avg Volume | 0 |
| Revenue (TTM) | $7.12M |
| Net Income | $-259.50M |
| Gross Margin | 0.00% |
9 analysts cover NAMS: 0 strong buy, 9 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $53.29.